Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Laboratory Co. of America (LH) Competitors

$193.41
+0.91 (+0.47%)
(As of 05/30/2024 ET)

LH vs. DGX, DVA, CHE, RCM, CRVL, AMED, AMN, MD, CCRN, and NTRA

Should you be buying Laboratory Co. of America stock or one of its competitors? The main competitors of Laboratory Co. of America include Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), and Natera (NTRA).

Laboratory Co. of America vs.

Laboratory Co. of America (NYSE:LH) and Quest Diagnostics (NYSE:DGX) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.5%. Quest Diagnostics pays an annual dividend of $2.84 per share and has a dividend yield of 2.1%. Laboratory Co. of America pays out 57.9% of its earnings in the form of a dividend. Quest Diagnostics pays out 38.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Laboratory Co. of America and Laboratory Co. of America both had 9 articles in the media. Laboratory Co. of America's average media sentiment score of 1.09 beat Quest Diagnostics' score of 1.03 indicating that Laboratory Co. of America is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quest Diagnostics
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Quest Diagnostics has lower revenue, but higher earnings than Laboratory Co. of America. Quest Diagnostics is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$12.16B1.33$418M$4.9738.73
Quest Diagnostics$9.25B1.66$854M$7.4318.60

Quest Diagnostics has a net margin of 9.11% compared to Laboratory Co. of America's net margin of 3.52%. Quest Diagnostics' return on equity of 15.52% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America3.52% 14.68% 7.03%
Quest Diagnostics 9.11%15.52%7.23%

95.9% of Laboratory Co. of America shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Laboratory Co. of America shares are owned by company insiders. Comparatively, 0.8% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Laboratory Co. of America has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.

Laboratory Co. of America presently has a consensus price target of $243.14, suggesting a potential upside of 26.31%. Quest Diagnostics has a consensus price target of $146.17, suggesting a potential upside of 5.77%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, research analysts clearly believe Laboratory Co. of America is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79
Quest Diagnostics
0 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

Laboratory Co. of America received 79 more outperform votes than Quest Diagnostics when rated by MarketBeat users. Likewise, 64.14% of users gave Laboratory Co. of America an outperform vote while only 49.53% of users gave Quest Diagnostics an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
601
64.14%
Underperform Votes
336
35.86%
Quest DiagnosticsOutperform Votes
522
49.53%
Underperform Votes
532
50.47%

Summary

Laboratory Co. of America beats Quest Diagnostics on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LH vs. The Competition

MetricLaboratory Co. of AmericaMedical laboratories IndustryMedical SectorNYSE Exchange
Market Cap$16.23B$2.28B$5.05B$17.75B
Dividend Yield1.47%1.81%2.82%3.54%
P/E Ratio38.7311.01121.3822.06
Price / Sales1.33123.212,437.0610.29
Price / Cash9.65340.5734.5019.29
Price / Book2.043.905.435.82
Net Income$418M-$132.05M$105.53M$975.72M
7 Day Performance-2.31%-1.00%0.59%-0.51%
1 Month Performance-4.40%-0.27%2.49%2.67%
1 Year Performance-9.17%-10.69%5.32%22.10%

Laboratory Co. of America Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DGX
Quest Diagnostics
4.9219 of 5 stars
$141.28
+0.9%
$146.17
+3.5%
+3.3%$15.69B$9.25B19.0148,000Analyst Forecast
Positive News
DVA
DaVita
3.0203 of 5 stars
$138.54
+4.8%
$144.67
+4.4%
+55.6%$12.15B$12.34B15.7470,000Positive News
CHE
Chemed
4.8245 of 5 stars
$555.37
+0.0%
$673.50
+21.3%
-0.2%$8.41B$2.26B29.8915,087
RCM
R1 RCM
4.7537 of 5 stars
$12.48
+2.9%
$16.31
+30.7%
-19.8%$5.26B$2.31B-156.0030,000Positive News
CRVL
CorVel
0.3823 of 5 stars
$276.60
+0.3%
N/A+24.7%$4.73B$795.31M62.864,444Analyst Downgrade
Insider Selling
Short Interest ↑
News Coverage
AMED
Amedisys
2.9543 of 5 stars
$96.23
+0.0%
$100.80
+4.7%
+23.7%$3.14B$2.24B-150.3619,000News Coverage
High Trading Volume
AMN
AMN Healthcare Services
4.9106 of 5 stars
$56.24
-0.8%
$75.57
+34.4%
-43.8%$2.14B$3.79B15.123,585Analyst Forecast
Positive News
MD
Pediatrix Medical Group
2.0998 of 5 stars
$7.46
-1.7%
$9.38
+25.7%
-45.7%$627.76M$1.99B-8.785,170
CCRN
Cross Country Healthcare
4.6748 of 5 stars
$14.50
+1.6%
$20.83
+43.7%
-43.9%$504.17M$2.02B11.1510,831Insider Selling
NTRA
Natera
1.8799 of 5 stars
$109.51
+1.9%
$98.47
-10.1%
+125.9%$13.45B$1.08B-35.103,293

Related Companies and Tools

This page (NYSE:LH) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners